Candriam S.C.A. Abbott Laboratories Transaction History

Candriam S.C.A.

$16.3 Billion
Q2 2024

A detailed history of Candriam S.C.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Candriam S.C.A. holds 359,676 shares of ABT stock, worth $40.8 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

359,676

Previous 303,509 18.51%

Holding current value

$40.8 Million

Previous $34.5 Million 8.34%

% of portfolio

0.23%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$100.73 - $112.44 $5.66 Million - $6.32 Million	56,167 Added 18.51%	359,676 $37.4 Million
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $35.4 Million - $39.1 Million	-322,925 Reduced 51.55%	303,509 $34.5 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $10.7 Million - $13.1 Million	-119,098 Reduced 15.97%	626,434 $69 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $9.97 Million - $12 Million	-104,370 Reduced 12.28%	745,532 $72.2 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $4.7 Million - $5.23 Million	-46,599 Reduced 5.2%	849,902 $92.7 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $14.4 Million - $16.9 Million	-148,229 Reduced 14.19%	896,501 $90.8 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $8.77 Million - $10.3 Million	-92,209 Reduced 8.11%	1,044,730 $115 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $28.4 Million - $32.9 Million	293,977 Added 34.87%	1,136,939 $110 Million
Q2 2022 Aug 03, 2022	BUY	$102.07 - $123.37 $3.1 Million - $3.75 Million	30,372 Added 3.74%	842,962 $91.6 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $3.07 Million - $3.74 Million	26,892 Added 3.42%	812,590 $96.2 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $23.6 Million - $28.9 Million	204,459 Added 35.18%	785,698 $111 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $9.25 Million - $10.2 Million	-79,305 Reduced 12.01%	581,239 $68.7 Million
Q2 2021 Jul 20, 2021	BUY	$105.79 - $124.53 $20.4 Million - $24 Million	192,623 Added 41.17%	660,544 $76.6 Million
Q1 2021 Apr 29, 2021	BUY	$108.84 - $128.23 $435 - $512	4 Added 0.0%	467,921 $49.2 Million
Q4 2020 Jan 22, 2021	SELL	$105.0 - $114.42 $13.9 Million - $15.2 Million	-132,853 Reduced 22.11%	467,917 $51.2 Million
Q3 2020 Oct 19, 2020	BUY	$91.64 - $111.29 $11.4 Million - $13.9 Million	124,711 Added 26.2%	600,770 $65.4 Million
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $13.8 Million - $17.7 Million	-180,303 Reduced 27.47%	476,059 $43.5 Million
Q1 2020 May 26, 2020	BUY	$62.82 - $91.86 $1,005 - $1,469	16 Added 0.0%	656,362 $55.7 Million
Q4 2019 Jan 21, 2020	SELL	$78.51 - $87.4 $3.2 Million - $3.56 Million	-40,718 Reduced 5.84%	656,346 $57,000
Q3 2019 Oct 21, 2019	SELL	$81.84 - $88.74 $1.53 Million - $1.66 Million	-18,753 Reduced 2.62%	697,064 $58,000
Q2 2019 Aug 01, 2019	BUY	$72.88 - $85.0 $10.9 Million - $12.8 Million	150,066 Added 26.53%	715,817 $59.9 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $3.11 Million - $3.75 Million	-46,893 Reduced 7.65%	565,751 $45.2 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $1.84 Million - $2.08 Million	28,026 Added 4.79%	612,644 $44.3 Million
Q3 2018 Nov 07, 2018	SELL	$60.81 - $73.36 $2.61 Million - $3.15 Million	-42,892 Reduced 6.84%	584,618 $42.9 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $88,024 - $97,152	-1,529 Reduced 0.24%	627,510 $38.3 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $10.3 Million - $11.7 Million	183,537 Added 41.2%	629,039 $37.7 Million
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $795,322 - $851,475	-14,816 Reduced 3.22%	445,502 $25.4 Million
Q3 2017 Nov 03, 2017	BUY	$48.06 - $53.64 $22.1 Million - $24.7 Million	460,318	460,318 $24.6 Million

Others Institutions Holding ABT

# of Institutions

3,162

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account